GP
AZN icon

Guardian Partners’s AstraZeneca AZN Stock Holding History

Guardian Partners’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-22,291
Closed -$3.76M – 204
2025
Q3 		$3.76M Sell
22,291
-175
-0.8% -$26.5K 0.32% 68
2025
Q2 		$3.18M Sell
22,466
-1,023
-4% -$143K 0.29% 76
2025
Q1 		$3.22M Sell
23,489
-293
-1% -$42.4K 0.33% 75
2024
Q4 		$3.17M Buy
+23,782
New +$3.33M 0.32% 74

Other funds holding AZN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Guardian Partners's AZN Position: Q4 2025 in Review

Guardian Partners sold out of AstraZeneca (AZN) in Q4 2025, closing a stake of 22,291 shares — an estimated $3.76M sold.

Guardian Partners first reported a position in AZN in Q4 2024 and held it in 4 quarters. The position peaked at $3.76M in Q3 2025. 1,405 funds tracked by Wall St. Rank hold AZN as of Q4 2025.

  • Guardian Partners reported no remaining AstraZeneca position as of Q4 2025 after selling out during the quarter.
  • Guardian Partners sold 22,291 AstraZeneca shares in Q4 2025, an estimated $3.76M.
  • Guardian Partners first reported a position in AstraZeneca in Q4 2024 and held it in 4 quarters.
  • Guardian Partners's AstraZeneca position peaked at $3.76M in Q3 2025.
  • 1,405 funds tracked by Wall St. Rank held AstraZeneca as of Q4 2025.

Based on Guardian Partners's 13F filing for Q4 2025, filed 17 Feb 2026.